Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Eagle Pharmaceuticals, Inc. (EGRX)

« Back to company index

EGRX Chatter Timeline

Stock Ticker for EGRX

Most Active Tweeters for EGRX

UserTweets
@whatsonthorold2 3
@ZolmaxNews 3
@bibeypost_stock 2
@ThisLincolnian 2
@WeekHerald 2

Recent Tweets for EGRX

TickerReport @TickerReport
Zacks Investment Research Upgrades Eagle Pharmaceuticals $EGRX to Buy https://t.co/lkpJ97tyn3
January 18th 2019, 10:01pm
BlueBioNow @BlueBioNow
$EGRX Looking for any entry here......... ;) https://t.co/Ex00yeGooV
January 17th 2019, 11:01pm
SwingTradeBot @SwingTradeBot
Rose Above Upper Bollinger Band today: $EGRX $SONO ... https://t.co/AyIukUGmib
January 17th 2019, 12:01pm
whatsonthorold2 @whatsonthorold2
Are Analysts Bullish Eagle Pharmaceuticals, Inc. $EGRX After Last Week? https://t.co/nY4Pax8LMZ
January 16th 2019, 11:01am
reurope_stock @reurope_stock
Holder Opaleye Management INC Has Boosted Eagle Pharmaceuticals INC $EGRX Position https://t.co/IEXHaDbb2V
January 16th 2019, 10:01am
thefinreviewer @thefinreviewer
Sector Gamma As Cut Its Portola Pharmaceuticals $PTLA Holding as Valuation Declined; Eagle Pharmaceuticals $EGRX Ho… https://t.co/Hn6fSHIiQH
January 15th 2019, 10:01am
ZolmaxNews @ZolmaxNews
Eagle Pharmaceuticals Inc $EGRX Receives $68.00 Consensus Target Price from Analysts https://t.co/YxFl4FExgl
January 8th 2019, 4:01pm
dailypoliticaln @dailypoliticaln
Eagle Pharmaceuticals Inc $EGRX Given Consensus Recommendation of “Hold” by Analysts https://t.co/ELNU8hZu5b
January 8th 2019, 4:01pm
ThisLincolnian @ThisLincolnian
Eagle Pharmaceuticals Inc $EGRX Expected to Post Quarterly Sales of $51.15 Million https://t.co/HDJPCdcCOi
January 7th 2019, 11:01pm
WeekHerald @WeekHerald
Analysts Anticipate Eagle Pharmaceuticals Inc $EGRX Will Post Quarterly Sales of $51.15 Million https://t.co/4CwtVNs3YB
January 7th 2019, 11:01pm
InsiderAlertsIA @InsiderAlertsIA
$EGRX: New Insider Filing on CEO SCOTT TARRIFF: https://t.co/ADxF2pc4SP
January 7th 2019, 9:01am
marketexclusive @marketexclusive
$EGRX Eagle Pharmaceuticals,Inc. (NASDAQ:EGRX) Files An 8-K Regulation FD Disclosure https://t.co/8VQ5cdoQSh
January 7th 2019, 9:01am
WatchlistN @WatchlistN
Insider Selling: Eagle Pharmaceuticals Inc $EGRX CEO Sells 31,569 Shares of Stock https://t.co/VscS1TAbOW
January 7th 2019, 4:01am
mmahotstuff1 @mmahotstuff1
How Many Eagle Pharmaceuticals, Inc. $EGRX's Analysts Are Bullish? - https://t.co/diS5Ephupk
January 6th 2019, 11:01am
whatsonthorold2 @whatsonthorold2
Were Analysts Bearish Eagle Pharmaceuticals, Inc. $EGRX This Week? - https://t.co/EalvgJHOvk
January 6th 2019, 11:01am
bibeypost_stock @bibeypost_stock
Eagle Pharmaceuticals, Inc. $EGRX has analysts on the Bullish side this week. - https://t.co/bEt571ddIr
January 6th 2019, 11:01am
reurope_stock @reurope_stock
Were Analysts Bearish Eagle Pharmaceuticals, Inc. $EGRX This Week? https://t.co/XBEOKqKXHX
January 6th 2019, 11:01am
WeekHerald @WeekHerald
Analysts Set Eagle Pharmaceuticals Inc $EGRX PT at $68.00 https://t.co/u2Nq2TTVkY
January 6th 2019, 11:01am
ThisLincolnian @ThisLincolnian
Eagle Pharmaceuticals Inc $EGRX Receives $68.00 Average Price Target from Analysts https://t.co/uMLiwgYYDj
January 6th 2019, 10:01am
ZolmaxNews @ZolmaxNews
Scott Tarriff Sells 31,569 Shares of Eagle Pharmaceuticals Inc $EGRX Stock https://t.co/RkVdyzr4KY
January 6th 2019, 4:01am
registrarjourn @registrarjourn
$51.15 Million in Sales Expected for Eagle Pharmaceuticals Inc $EGRX This Quarter https://t.co/wOepgKP1mR
January 5th 2019, 7:01pm
EnterpriseLeade @EnterpriseLeade
$51.15 Million in Sales Expected for Eagle Pharmaceuticals Inc $EGRX This Quarter https://t.co/Uo8e4TY4X5
January 5th 2019, 7:01pm
OlympiaReport @OlympiaReport
Eagle Pharmaceuticals Inc $EGRX CEO Sells $1,246,659.81 in Stock https://t.co/8N6qj3zkkv
January 5th 2019, 10:01am
dispatchtribune @dispatchtribune
Eagle Pharmaceuticals Inc $EGRX CEO Scott Tarriff Sells 31,569 Shares of Stock https://t.co/oYShpVGnqA
January 5th 2019, 10:01am
mmahotstuff1 @mmahotstuff1
How Analysts Feel About Eagle Pharmaceuticals Inc $EGRX After Increase in Sellers? - https://t.co/sguUuWqRkz
January 5th 2019, 8:01am
whatsonthorold2 @whatsonthorold2
Is Eagle Pharmaceuticals Inc $EGRX’s Fuel Running Low? Reports Show More Sellers - https://t.co/LHm7jr522R
January 5th 2019, 8:01am
bibeypost_stock @bibeypost_stock
It Seems Eagle Pharmaceuticals Inc $EGRX Will Go Down. Just Reported More Shorted Shares - https://t.co/mqjT4PkZDw
January 5th 2019, 8:01am
dailypoliticaln @dailypoliticaln
Zacks Investment Research Downgrades Eagle Pharmaceuticals $EGRX to Hold https://t.co/H5eXBOh4Vg
January 5th 2019, 4:01am
ZolmaxNews @ZolmaxNews
Zacks Investment Research Downgrades Eagle Pharmaceuticals $EGRX to Hold https://t.co/RT1HC4ePem
January 5th 2019, 4:01am
ConsumerFeed @ConsumerFeed
Eagle Pharmaceuticals CEO Scott Tarriff Sells $1,246,659.81 in $EGRX https://t.co/nfbxMoxmCb
January 5th 2019, 3:01am
insiderbuyings @insiderbuyings
$EGRX new insider selling: 31569 shares. https://t.co/2fJN3JVgN6
January 4th 2019, 10:01pm
WeekHerald @WeekHerald
Eagle Pharmaceuticals Inc $EGRX CEO Sells $1,246,659.81 in Stock https://t.co/OwVTW5pEnx
January 4th 2019, 10:01pm
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals Inc $EGRX CEO Sells $1,246,659.81 in Stock https://t.co/3TpoE8xfWW #stocks
January 4th 2019, 10:01pm
ThisLincolnian @ThisLincolnian
Insider Selling: Eagle Pharmaceuticals Inc $EGRX CEO Sells 31,569 Shares of Stock https://t.co/AFDQwmXz6x
January 4th 2019, 10:01pm
StockTexts @StockTexts
$EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/cSxkm41xSY
January 4th 2019, 9:01pm
bbnsnews @bbnsnews
Zacks Investment Research Downgrades Eagle Pharmaceuticals $EGRX to Hold https://t.co/VTtUUNuuJ0
January 4th 2019, 11:01am
dakotafinancial @dakotafinancial
Analysts Set Eagle Pharmaceuticals Inc $EGRX Price Target at $68.00 https://t.co/RpZxoWVSBX
January 4th 2019, 9:01am
1stOncology @1stOncology
#EaglePharmaceuticals, Inc. to Present at 37th Annual J.P. Morgan #HealthcareConference $EGRX https://t.co/5drSX63OoU
January 4th 2019, 3:01am
SwingTradeBot @SwingTradeBot
Outside Day today: $LGND $EGRX ... https://t.co/Ya1wmaeD73
January 3rd 2019, 3:01pm
HottestStockNow @HottestStockNow
$EGRX to Present a Corporate Overview at Upcoming Conference https://t.co/LzVyZVLnGh
January 2nd 2019, 9:01am
mmahotstuff1 @mmahotstuff1
How Analysts Rated Eagle Pharmaceuticals, Inc. $EGRX Last Week? - https://t.co/926uS48IiH
January 2nd 2019, 8:01am
reurope_stock @reurope_stock
Analysts are on the Bearish side about Eagle Pharmaceuticals, Inc. $EGRX this week. https://t.co/WhFRLS9zmQ
January 2nd 2019, 8:01am
ConsumerFeed @ConsumerFeed
Eagle Pharmaceuticals $EGRX Lowered to Hold at Zacks Investment Research https://t.co/11UmN5GwAc
January 2nd 2019, 4:01am
dakotafinancial @dakotafinancial
Eagle Pharmaceuticals $EGRX Rating Lowered to Hold at Zacks Investment Research https://t.co/tZjUttCD04
January 1st 2019, 11:01pm
bbnsnews @bbnsnews
Eagle Pharmaceuticals Inc $EGRX Given Consensus Rating of “Hold” by Brokerages https://t.co/uECTwo3ny6
January 1st 2019, 9:01am
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals Inc $EGRX Receives Consensus Recommendation of “Hold” from Analysts https://t.co/ScmD05mcb9 #stocks
January 1st 2019, 9:01am
AlertTrade @AlertTrade
TREND REVERSAL UP ALERT: $EGRX Eagle Pharmaceuticals, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room
December 31st 2018, 3:12pm
AmericanBanking @AmericanBanking
Zacks: Analysts Anticipate Eagle Pharmaceuticals Inc $EGRX Will Post Quarterly Sales of $51.15 Million https://t.co/eSWe8hWnEf #stocks
December 31st 2018, 4:12am
OlympiaReport @OlympiaReport
$51.15 Million in Sales Expected for Eagle Pharmaceuticals Inc $EGRX This Quarter https://t.co/snOxYPukwJ
December 31st 2018, 4:12am
dispatchtribune @dispatchtribune
Zacks: Analysts Anticipate Eagle Pharmaceuticals Inc $EGRX Will Post Quarterly Sales of $51.15 Million https://t.co/6v7ljvVBZu
December 31st 2018, 4:12am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.